Trend of accesses to the ED of Teaching Hospital of Tuscany for bronchiolitis 2018-2023: new emergency

Versions

pdf

Keywords

Bronchiolitis
Acute Respiratory Infections

Abstract

Introduction: Acute bronchiolitis is the leading cause of lower respiratory tract infection and hospitalisation in children less than one year old worldwide. The aim of our study is to analyse paediatric accesses of children with bronchiolitis to the Emergency Department (ED) of Teaching Hospital (AOUS), Santa Maria alle Scotte of Siena, Tuscany

Methods: A retrospective observational study was conducted on the accesses performed at the ED of the AOUS of Siena by children under 18 years of age suffering from bronchiolitis from September 2018 to April 2023.

Results: There were 36031 patients between 0 and 18 years old in the Emergency Department, 383 of which presented bronchiolitis (age 4.8 months C.I.:3.5-6 months.; 54% male). Those who accessed the ED with a higher priority code were more likely to be subsequently admitted (O.R.:2.6; C.I.:1.3-5.1; p<0.01). Those who accessed the ED with symptoms of bronchiolitis during the weekend were less likely to have been sent from community medicine services or professionals (O.R:0.1; C.I:0.0-0.5; p<0.001). Children below 1 year old were more likely to access the ED with respiratory distress symptoms (O.R.:2.6; C.I.:1.5-4.3; p<0.001). Finally, those who accessed the ED with bronchiolitis were more likely to be admitted than those who accessed for other conditions (O.R:24.5; C.I.:19.4-31; p<0.001).

Conclusions: It is necessary to invest protocols integrating hospital services and community medicine in order to achieve a timely diagnosis and to reduce the accesses to the ED of children presenting mild, non-severe form of bronchiolitis  in order to avoid the overload of hospital services

https://doi.org/10.15167/2421-4248/jpmh2024.65.2.3204
pdf

References

References

Baraldi E., Lanari M., Manzoni, P. et al. Inter-society consensus document on treatment and prevention of bronchiolitis in newborns and infants. Ital J Pediatr 40, 65 (2014). doi: 10.1186/1824-7288-40-65

Friedman JN, Rieder MJ, Walton JM; Canadian Paediatric Society, Acute Care Committee, Drug Therapy and Hazardous Substances Committee. Bronchiolitis: Recommendations for diagnosis, monitoring and management of children one to 24 months of age. Paediatr Child Health. 2014 Nov;19(9):485-98. doi: 10.1093/pch/19.9.485.

Centers for Disease Control and Prevention. RSV in infants and young children. 2020. Available at: https://www.cdc.gov/rsv/high-risk/infants-young-children.html Accessed on July 2023

Meissner HC. Viral Bronchiolitis in Children. N Engl J Med. 2016 May 5;374(18):1793-4. doi: 10.1056/NEJMc1601509.

Shi T, McAllister DA, O'Brien KL, Simoes EAF, Madhi SA, Gessner BD, et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study. Lancet. 2017;390(10098):946–58.

Obando-Pacheco P, Justicia-Grande AJ, Rivero-Calle I, Rodríguez-Tenreiro C, Sly P, Ramilo O, Mejías A, et al. Respiratory Syncytial Virus Seasonality: A Global Overview. J Infect Dis. 2018 Apr 11;217(9):1356-1364. doi: 10.1093/infdis/jiy056. PMID: 29390105.

Cucinotta D, Vanelli M. WHO Declares COVID-19 a Pandemic. Acta Biomed. 2020 Mar 19;91(1):157-160. doi: 10.23750/abm.v91i1.9397.

DPCME Decreto del Presidente del Consiglio dei Ministri 09 marzo 2020. Available at https://www.trovanorme.salute.gov.it/norme/dettaglioAtto?id=73629 Accessed on July 2023

DPCM Decreto del Presidente del Consiglio dei Ministri 3 novembre 2020. Available at https://www.miur.gov.it/documents/20182/0/m_pi.AOODPIT.REGISTRO+UFFICIALE%28U%29.0001990.05-11-2020.pdf/f37c907d-f834-d277-f439-ea40ae408093?t=1604594338648 Accessed on July 2023

Faraguna, M.C., Lepri, I., Clavenna, A. et al. The bronchiolitis epidemic in 2021–2022 during the SARS-CoV-2 pandemic: experience of a third level centre in Northern Italy. Ital J Pediatr 49, 26 (2023). doi: 10.1186/s13052-023-01425-8

EpiCentro - L'epidemiologia per la sanità pubblica. Available at https://www.epicentro.iss.it/influenza/aggiornamenti Accessed on July 2023

Giuseppe Indolfi et al, Outbreak of Respiratory Syncytial Virus Bronchiolitis in Italy, Clinical Infectious Diseases, Volume 75, Issue 3, 1 August 2022, Pages 549–550, doi: 10.1093/cid/ciac120

Sistema di Sorveglianza Sentinella delle sindromi simil- influenzali, dei virus influenzali, del virus SARS-CoV-2 e di altri virus respiratori. Available at: https://www.salute.gov.it/imgs/C_17_pubblicazioni_3267_allegato.pdf Accessed on July 2023

Manti S, Staiano A, Orfeo L, Midulla F, Marseglia GL, Ghizzi C, Zampogna S, et al. UPDATE - 2022 Italian guidelines on the management of bronchiolitis in infants. Ital J Pediatr. 2023 Feb 10;49(1):19. doi: 10.1186/s13052-022-01392-6.

Dalziel S, Haskell L, O'Brien S, Borland M, Plint A, et al, Bronchiolitis, The Lancet,Volume 400, Issue 10349,2022,Pages 392-406,ISSN 0140-6736, doi: 10.1016/S0140-6736(22)01016-9.

Team, Bronchiolitis Guideline. "Cincinnati Children’s Hospital Medical Center: Evidence based clinical practice guideline for medical management of bronchiolitis in infants 1 year of age or less presenting with a first time episode." Cincinnati Child. Hosp. Med. Cent 1 (2010): 1-13.

van Woensel JB, Kimpen JL, Sprikkelman AB, Ouwehand A, van Aalderen WM. Long-term effects of prednisolone in the acute phase of bronchiolitis caused by respiratory syncytial virus. Pediatr Pulmonol. 2000 Aug;30(2):92-6. doi: 10.1002/1099-0496(200008)30:2<92::aid-ppul3>3.0.co;2-x. PMID: 10922130.

Rinawi F, Kassis I, Tamir R, Kugelman A, Srugo I, Miron D. Bronchiolitis in young infants: is it a risk factor for recurrent wheezing in childhood? World J Pediatr. 2017 Feb;13(1):41-48. doi: 10.1007/s12519-016-0056-4. Epub 2016 Sep 15.

Driscoll AJ, Arshad SH, Bont L, Brunwasser SM, Cherian T, Englund JA, et al. Does respiratory syncytial virus lower respiratory illness in early life cause recurrent wheeze of early childhood and asthma? Critical review of the evidence and guidance for future studies from a World Health Organization-sponsored meeting. Vaccine. 2020 Mar 4;38(11):2435-2448. doi: 10.1016/j.vaccine.2020.01.020. Epub 2020 Jan 20.

Bozzola E, Ciarlitto C, Guolo S, Brusco C, Cerone G, Antilici L, et al. Respiratory Syncytial Virus Bronchiolitis in Infancy: The Acute Hospitalization Cost. Front Pediatr. 2021 Jan 18;8:594898. doi: 10.3389/fped.2020.594898.

Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020 May;109:102433. doi: 10.1016/j.jaut.2020.102433. Epub 2020 Feb 26.

DPCM Decreto Presidente Consiglio dei Ministri 1 marzo 2020. Available at https://www.salute.gov.it/portale/news/p3_2_1_1_1.jsp?menu=notizie&id=4137 Accessed on July 2023

InfluNet Available at

https://www.salute.gov.it/portale/temi/documenti/epidemiologica/Influnet_2021_2.pdf Accessed on July 2023

Pellegrinelli L, Galli C, Bubba L, Seiti A, Anselmi G, Primache V, et al. Respiratory syncytial virus in pediatric influenza-like illness cases in Lombardy, Northern Italy, during seven consecutive winter seasons (from 2014-2015 to 2020-2021). Influenza Other Respir Viruses. 2022 May;16(3):481-491. doi: 10.1111/irv.12940. Epub 2021 Dec 17.

Capitani E, Montomoli E, Camarri A, Bova G, Capecchi PL, Mercone A, Nante N, Manini I. Epidemiological and virological surveillance of Severe Acute Respiratory Infections in the 2019/2020 season in Siena, Tuscany, Italy. J Prev Med Hyg. 2021 Sep 15;62(3):E782-E788. doi: 10.15167/2421-4248/jpmh2021.62.3.2297.

Bardsley M, Morbey R, Hughes H, Beck C, et al, Epidemiology of respiratory syncytial virus in children younger than 5 years in England during the COVID-19 pandemic, measured by laboratory, clinical, and syndromic surveillance: a retrospective observational study, The Lancet Infectious Diseases,Volume 23, Issue 1,2023,Pages 56-66,ISSN 1473-3099, doi: 10.1016/S1473-3099(22)00525-4.

Stein RT, Zar HJ. RSV through the COVID-19 pandemic: Burden, shifting epidemiology, and implications for the future. Pediatr Pulmonol. 2023 Jun;58(6):1631-1639. doi: 10.1002/ppul.26370. Epub 2023 Mar 3. PMID: 36811330.

Intensified circulation of respiratory syncytial virus (RSV) and associated hospital burden in the EU/EEA Available at https://www.ecdc.europa.eu/en/publications-data/intensified-circulation-respiratory-syncytial-virus-rsv-and-associated-hospital Accessed on July 2023

Napolitani M, Guarducci G, Abinova G, Messina G, Nante N. How to Improve the Drafting of Health Profiles. International Journal of Environmental Research and Public Health. 2022; 19(6):3452. doi: 10.3390/ijerph19063452

DPCM Decreto Presidente Consiglio dei Ministri 23 maggio 2022, n. 77. Available at https://www.gazzettaufficiale.it/eli/id/2022/06/22/22G00085/sg Accessed on July 2023

Limaj S, D’Amato MG, Turillazzi R, Dei S. Management of chronicity and emergencies with telemedicine: the USL Toscana Sud-Est experience Sistema Salute, 66, 4 2022: pp. 447-460. DOI: 10.48291/SISA.66.4.5